E. Lin
Impact in
- Gastroenterology top 2%
- Gastrointestinal Tumor Research and Treatment
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 14
- Colorectal Cancer Treatments and Studies 8
- Cancer Treatment and Pharmacology 5
- Colorectal Cancer Surgical Treatments 3
- Cancer Cells and Metastasis 2
- Co-authors
- Scott Kopetz (5 shared papers)Saira Ahmed (3 shared papers)Jean‐Pierre J. Issa (3 shared papers)Lanlan Shen (3 shared papers)Yi Guo (2 shared papers)Yutaka Kondo (2 shared papers)Horng‐Jyh Harn (2 shared papers)Tzyy‐Wen Chiou (2 shared papers)
- Journals
- Journal of Clinical Oncology (12 papers)Cancer (2 papers)Clinical Cancer Research (1 paper)Blood (1 paper)CHEST Journal (1 paper)
- Partner nations
- United StatesGermanyTaiwan
In The Last Decade
E. Lin
35 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 100
- Gastroenterology 178
- Hepatology 185
- Oncology 636
- Cancer Research 347
- Hematology 238
Countries citing papers authored by E. Lin
This map shows the geographic impact of E. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Lin more than expected).
Fields of papers citing papers by E. Lin
This network shows the impact of papers produced by E. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Lin. The network helps show where E. Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 451 | |
| 2 | 2009 | 279 | |
| 3 | 2019 | 209 | |
| 4 | 2009 | 181 | |
| 5 | 2008 | 132 | |
| 6 | 2013 | 101 | |
| 7 | 2010 | 96 | |
| 8 | 2006 | 93 | |
| 9 | 2014 | 74 | |
| 10 | 2006 | 72 | |
| 11 | 2010 | 61 | |
| 12 | 2008 | 54 | |
| 13 | Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma: a retrospective analysis. | 2011 | 52 |
| 14 | 2007 | 41 | |
| 15 | 2010 | 39 | |
| 16 | 2006 | 32 | |
| 17 | 2011 | 30 | |
| 18 | 2011 | 30 | |
| 19 | 1992 | 24 | |
| 20 | 2011 | 22 |
About E. Lin
E. Lin is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Surgery and Pathology and Forensic Medicine, having authored 35 papers that have together received 2.2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (8 papers), Cancer Treatment and Pharmacology (5 papers), Acute Myeloid Leukemia Research (3 papers), Colorectal Cancer Surgical Treatments (3 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer Cells and Metastasis (2 papers), Colorectal and Anal Carcinomas (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). The work is most often cited by research in Gastroenterology (178 citations), Hepatology (185 citations), Oncology (636 citations), Cancer Research (347 citations) and Hematology (238 citations). E. Lin has collaborated with scholars based in United States, Germany and Taiwan. Frequent co-authors include Scott Kopetz, Saira Ahmed, Jean‐Pierre J. Issa, Lanlan Shen, Yi Guo, Yutaka Kondo, Horng‐Jyh Harn, Tzyy‐Wen Chiou, Yu-Shuan Chen and James L. Abbruzzese. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Clinical Cancer Research, Blood and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.